The medical landscape for blood sugar is shifting, and GLP-1 patches represent a potential development. Unlike subcutaneous injections, this approach offers a less invasive way to provide GLP-1 therapies. These devices gradually release the treatment through the surface offering a stable dose of the therapeutic agent, which can enhance blood sugar